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Abstract 
Background: To note association of glycemic 
control with lipid profile abnormalities in patients 
with type 2 diabetes mellitus (T2DM). 
Methods: In this cross sectional fasting blood 
samples of 226 T2DM were collected for glycosylated 
haemoglobin (HbA1c) and lipid profile. Association 
between glycemic control and lipid profile 
abnormalities were sought employing Chi2 or t test.  
Results: Mean patient age was 58.70±7.725 years. 
Majority (54%) patients were female. Mean HbA1C 
level was 9.6±2.06. Majority (81.4%) had poorly 
controlled diabetes. Dyslipidemia was noted in 
80.1%. Significant association was noted between 
poor glycemic control and dyslipidemia (p <0.05). 
Conclusion: Poor glycemic control is common in 
our type II DM patients. Significant association 
exists between glycemic control and presence or 
absence of dyslipidemia. 
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Introduction 
          Type 2 diabetes mellitus (DM) is characterized 
by impaired insulin secretion and insulin resistance. 
Epidemiologic studies have demonstrated that DM is 
an independent risk factor for cardiovascular disease 
and it amplifies the effects of other common risk 
factors, such as smoking, hypertension and 
dyslipidemia.1,2 DM is an important secondary cause 
of dyslipidemia.1 Prevalence of dyslipidemia in type II 
diabetics is variable. Most common pattern of 
dyslipidemia in type 2 DM is elevated triglyceride 
level, decreased HDL cholesterol levels, and a 
preponderance of smaller and denser LDL particles.3,4 
Lipid changes associated with diabetes mellitus are 
attributed to increased free fatty acid flux secondary to 
insulin resistance. 
     Dyslipidemia associated macrovascular 
complications in type 2 DM, contribute to increased 
atherogenecity.5 Lipid profile abnormalities are 
common in uncontrolled type 2 DM. Optimal 
glycaemia control usually lead to a decline  
triglyceride and may also lower LDL cholesterol 
levels.6 Primary goal of managing type 2 DM is to 
achieve a good glycemic control so that associated 
lipid abnormalities do not add to cardiovascular risk 
factors.7 This study was conducted to determine 
whether patients with good glycemic control have 
better lipid profile compared to poorly controlled 
diabetics or not. 
 
Patients and Methods 
         This cross-sectional study was conducted at 
Department of Medicine, Holy Family Hospital 
Rawalpindi for six months. A total of 226 type 2 
diabetics were included by non probability 
consecutive sampling method . Patients with family 
history of dyslipidemia, hyperlipidemia due to other 
causes e.g. nephrotic syndrome, hypothyroidism, end 
stage renal disease, medications like thiazide diuretics, 
oral contraceptives, and corticosteroids, history of 
alcohol intake, cigarette smoking and patients already 
taking lipid lowering drugs were excluded. 
      Controlled glycemia was defined as glycated 
haemoglobin (HbA1c) <7%, HDL cholesterol > 40 
mg/dl, triglyceride <150mg/dl, LDL cholesterol < 100 
mg/dl, and total cholesterol <200 mg/dl were 
considered normal lipid profile. Blood samples for 
lipid profile were taken from each patient after they 
had been fasting for 10–12 hours. Lipid profile and 
HBA1c estimation were performed in standard way 
from the sample.Patients were divided into two 
groups; 1) Group I, with controlled glycaemia, and 2) 
Group II, with uncontrolled glycaemia. Chi2 or t test 
was used wherever appropriate to note statistical 
relationship between the two Groups and lipid profile 
abnormalities. 
 
Results 
        Of the 226 patients 104 (46%) were male, and 122 
(54%) female. Mean patient age was 58.70±7.725 years. 
Mean age of male patients was 59.22±8.01 and of 
female patients was 58.26±7.47 years respectively (p 
value 0.354). Mean HbA1c level of all patients was 
9.6±2.06. Majority (81.4%) of the  patients had poorly 
controlled diabetes. Mean cholesterol, triglycerides 
and LDL were more in Group II (Table 1). 
Hypertriglyceridemia (91.84%) and low HDL(49.455) 
were more pronounced in Group II (Table 2)   
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Table 1– Mean lipid values in Group I and II  
 Group I Group II p value 
Cholesterol (mg/dl) 120.28±23.05 180±26.54 0.00 
Triglyceride 
(mg/dl) 107.50±25.51 192.85±43.94 0.00 
HDL (mg/dl) 47.95±6.28 39.46±5.31 0.00 
LDL (mg/dl) 62.64±16.77 86.25±23.67 0.00 
Table 2– Lipid abnormalities in Group I and II 
  
Group I 
(n= 42) 
Group II 
(n=184) P value 
Hypercholesterolemia 0 34 (18.47%) 0.003 
Hypertriglyceridemia 2 (4.76%) 169 (91.84%) 0.00 
High LDL 0 19 (10.32%) 0.030 
Low HDL 4 (9.5%) 91 (49.45%0 0.00 
 
Discussion 
          Longer duration of diabetic illness and lack of 
medication compliance are considered important 
factors responsible for poor glycemic control in type II 
diabetics. Uncontrolled DM was frequently noted in 
our patients. Results similar to us have been noted 
earlier are in related studies. 46.7% patients had 
uncontrolled glycemia in a Pakistani study. In studies 
from Saudi Arabia, Jordan, and Kuwait 73%, 65.1%, 
and 66.7% patients respectively had poor glycemic 
control. Similar figures have been noted in studies 
conducted in UK as well.8 
       Insulin resistance in diabetics lead to efflux of free 
fatty acids which causes dyslipidemia.9 Lipid 
abnormalities are frequently noted in type 2 DM 
patients. Some form of dyslipidemia is noted in at least 
49% of type 2 diabetics.10 In a Pakistani study which 
evaluated dyslipidemia in type 2 diabetics, 54.7-82.7% 
patients had lipid abnormalities.11  
      In DM, cardiovascular diseases are important 
causes of morbidity and mortality.12 Diabetes related 
risk is considered equal to that of ischemic heart 
diseases.12 Hypertriglyceridemia, and elevated levels 
of low-density lipoprotein cholesterol along with 
decreased levels of high-density lipoprotein are 
important in pathogenesis of atherosclerosis in 
diabetics. Hypertriglyceridemia low HDL levels, 
hypercholesterolemia, and elevated LDL were noted 
by us in descending order of frequency. Results similar 
to our have been noted locally internationaly.11,13  It is 
interesting to note that in some local and international 
studies commonest pattern of dyslipadimia were high 
LDL and low HDL cholesterol levels.14,15 
    Glycated hemoglobin (HbA1c) is considered as a 
reliable marker of glycemic control in preceding 6-8 
weeks.16 Association between atherogenecity in 
plasma with HbA1c has already been known. 
Correlation exists between glycemic control and 
dyslipademia in type 2 DM patients. In local studies 
conducted by Amir W et al, Khan HA et al, and Ghani 
MH et al, dyslipidemia were more frequent in poorly 
controlled diabetics compared to diabetics with good 
glycemic control.16,17 
Conclusion 
1.Uncontrolled glycemia and dyslipidemia are 
common in type 2 DM patients.  
2.Dyslipidemia in terms of hypercholesterolemia, 
hypertriglyceridemia, high LDL and low HDL is 
significantly more frequent among uncontrolled 
diabetics.  
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